Ranjit Kumar Mehta
Overview
Explore the profile of Ranjit Kumar Mehta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
140
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pati R, Das I, Mehta R, Sahu R, Sonawane A
Toxicol Sci
. 2016 Jan;
150(2):454-72.
PMID: 26794139
Zinc oxide nanoparticles (ZnO-NPs) have wide biological applications, which have raised serious concerns about their impact on the health and environment. Although, various studies have shown ZnO-NP toxicity on different...
2.
Verma S, Mehta R, Maiti P, Rohm K, Sonawane A
Biochim Biophys Acta
. 2014 Apr;
1844(7):1219-30.
PMID: 24721562
Bacterial asparaginases (EC 3.5.1.1) have attracted considerable attention because enzymes of this group are used in the therapy of certain forms of leukemia. Class II asparaginase from Escherichia coli (EcA),...
3.
Pati R, Mehta R, Mohanty S, Padhi A, Sengupta M, Vaseeharan B, et al.
Nanomedicine
. 2014 Mar;
10(6):1195-208.
PMID: 24607937
From The Clinical Editor: This in-depth study demonstrates properties of ZnO nanoparticles in infection prevention and treatment in several skin infection models, dissecting the potential mechanisms of action of these...
4.
Mehta R, Verma S, Pati R, Sengupta M, Khatua B, Jena R, et al.
J Biol Chem
. 2013 Dec;
289(6):3555-70.
PMID: 24297177
L-Asparaginase-II from Escherichia coli (EcA) is a central component in the treatment of acute lymphoblastic leukemia (ALL). However, the therapeutic efficacy of EcA is limited due to immunogenicity and a...